Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence

The national opioid crisis has increased attention on the treatment of pregnant women with opioid use disorder (OUD). Recent literature reports an increase in opioid prescriptions during pregnancy and parallels between an increase in the prevalence of OUD during pregnancy and the number of women seeking OUD treatment (Bateman et al. 2014; Desai et al. 2014; Martin et al. 2015). American College of Obstetrics and Gynecologists (ACOG), 2012 and World Health Organization (WHO), 2014 Treatment Guidelines recommend medication-assisted treatment (MAT) with methadone or buprenorphine (BUP) during pregnancy in women with identified OUD.
Source: Drug and Alcohol Dependence - Category: Addiction Authors: Tags: Short communication Source Type: research